BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10793195)

  • 21. Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain.
    Oliveira MC; Parada CA; Veiga MC; Rodrigues LR; Barros SP; Tambeli CH
    Eur J Pain; 2005 Feb; 9(1):87-93. PubMed ID: 15629879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.
    Spelta V; Jiang LH; Surprenant A; North RA
    Br J Pharmacol; 2002 Mar; 135(6):1524-30. PubMed ID: 11906966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta.
    Choi YM; Jang JY; Jang M; Kim SH; Kang YK; Cho H; Chung S; Park MK
    Neuroscience; 2009 May; 160(3):587-95. PubMed ID: 19272429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous ATP potentiates only vasopressin secretion from neurohypophysial terminals.
    Knott TK; Marrero HG; Custer EE; Lemos JR
    J Cell Physiol; 2008 Oct; 217(1):155-61. PubMed ID: 18481265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of ATP receptor increases the cytosolic Ca(2+) concentration in ventral tegmental area neurons of rat brain.
    Sorimachi M; Yamagami K; Wakomori M
    Brain Res; 2002 May; 935(1-2):129-33. PubMed ID: 12062483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2'4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats.
    Kittner H; Krügel U; Illes P
    Neuroscience; 2001; 102(2):241-3. PubMed ID: 11166110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors.
    Neary JT; Kang Y; Tran M; Feld J
    J Neurotrauma; 2005 Apr; 22(4):491-500. PubMed ID: 15853465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption.
    Denda M; Inoue K; Fuziwara S; Denda S
    J Invest Dermatol; 2002 Nov; 119(5):1034-40. PubMed ID: 12445189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological evidence for the existence of multiple P2 receptors in the circular muscle of guinea-pig colon.
    Zagorodnyuk V; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):122-8. PubMed ID: 9484862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of phrenic motoneuron excitability by ATP: consequences for respiratory-related output in vitro.
    Miles GB; Parkis MA; Lipski J; Funk GD
    J Appl Physiol (1985); 2002 May; 92(5):1899-910. PubMed ID: 11960940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of adenosine triphosphate on sevoflurane requirements for minimum alveolar anesthetic concentration and minimum alveolar anesthetic concentration-awake.
    Suzuki A; Katoh T; Ikeda K
    Anesth Analg; 1998 Jan; 86(1):179-83. PubMed ID: 9428875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.
    Franke H; Kittner H; Grosche J; Illes P
    Psychopharmacology (Berl); 2003 May; 167(2):187-94. PubMed ID: 12652343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mechanism of inhibition by the P2 receptor antagonist PPADS of ATP-activated current in dorsal root ganglion neurons.
    Li C
    J Neurophysiol; 2000 May; 83(5):2533-41. PubMed ID: 10805655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purinergic P2 receptors modulate excitability but do not mediate pH sensitivity of RTN respiratory chemoreceptors.
    Mulkey DK; Mistry AM; Guyenet PG; Bayliss DA
    J Neurosci; 2006 Jul; 26(27):7230-3. PubMed ID: 16822980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.
    Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
    Br J Pharmacol; 1996 Dec; 119(7):1301-3. PubMed ID: 8968535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP released from astrocytes during swelling activates chloride channels.
    Darby M; Kuzmiski JB; Panenka W; Feighan D; MacVicar BA
    J Neurophysiol; 2003 Apr; 89(4):1870-7. PubMed ID: 12686569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage.
    Kimura H; Meguro T; Badr A; Zhang JH
    J Neurosurg; 2002 Jul; 97(1):129-35. PubMed ID: 12134903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for purinergic receptors in memory processing in young chicks.
    Cronin C; Edwards TM; Gibbs ME
    Behav Brain Res; 2011 Oct; 223(2):417-20. PubMed ID: 21600243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.